Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

Factors Influencing Acceptability and Perceived Impacts of a Mandatory ePortfolio Implemented by an Occupational Therapy Regulatory Organization.

Vachon B, Foucault ML, Giguère CÉ, Rochette A, Thomas A, Morel M.

J Contin Educ Health Prof. 2018 Winter;38(1):25-31. doi: 10.1097/CEH.0000000000000182.

PMID:
29261571
2.

Utilisation of an electronic portfolio to engage rehabilitation professionals in continuing professional development: results of a provincial survey.

Foucault ML, Vachon B, Thomas A, Rochette A, Giguère CÉ.

Disabil Rehabil. 2018 Jun;40(13):1591-1599. doi: 10.1080/09638288.2017.1300335. Epub 2017 Mar 14.

PMID:
28291951
3.

The molecular mechanism of thermostable α-galactosidases AgaA and AgaB explained by x-ray crystallography and mutational studies.

Merceron R, Foucault M, Haser R, Mattes R, Watzlawick H, Gouet P.

J Biol Chem. 2012 Nov 16;287(47):39642-52. doi: 10.1074/jbc.M112.394114. Epub 2012 Sep 25.

4.

Role for proteases and HLA-G in the pathogenicity of influenza A viruses.

Foucault ML, Moules V, Rosa-Calatrava M, Riteau B.

J Clin Virol. 2011 Jul;51(3):155-9. doi: 10.1016/j.jcv.2011.04.013. Epub 2011 May 25. Review.

PMID:
21612979
5.

Inducible expression eliminates the fitness cost of vancomycin resistance in enterococci.

Foucault ML, Depardieu F, Courvalin P, Grillot-Courvalin C.

Proc Natl Acad Sci U S A. 2010 Sep 28;107(39):16964-9. doi: 10.1073/pnas.1006855107. Epub 2010 Sep 10.

6.

UV and X-ray structural studies of a 101-residue long Tat protein from a HIV-1 primary isolate and of its mutated, detoxified, vaccine candidate.

Foucault M, Mayol K, Receveur-Bréchot V, Bussat MC, Klinguer-Hamour C, Verrier B, Beck A, Haser R, Gouet P, Guillon C.

Proteins. 2010 May 1;78(6):1441-56. doi: 10.1002/prot.22661.

PMID:
20034112
7.

In vivo bioluminescence imaging for the study of intestinal colonization by Escherichia coli in mice.

Foucault ML, Thomas L, Goussard S, Branchini BR, Grillot-Courvalin C.

Appl Environ Microbiol. 2010 Jan;76(1):264-74. doi: 10.1128/AEM.01686-09. Epub 2009 Oct 30.

8.

Fitness cost of VanA-type vancomycin resistance in methicillin-resistant Staphylococcus aureus.

Foucault ML, Courvalin P, Grillot-Courvalin C.

Antimicrob Agents Chemother. 2009 Jun;53(6):2354-9. doi: 10.1128/AAC.01702-08. Epub 2009 Mar 30.

9.

New combinations of mutations in VanD-Type vancomycin-resistant Enterococcus faecium, Enterococcus faecalis, and Enterococcus avium strains.

Depardieu F, Foucault ML, Bell J, Dubouix A, Guibert M, Lavigne JP, Levast M, Courvalin P.

Antimicrob Agents Chemother. 2009 May;53(5):1952-63. doi: 10.1128/AAC.01348-08. Epub 2009 Mar 2.

10.

Crystallization and preliminary X-ray diffraction studies of two thermostable alpha-galactosidases from glycoside hydrolase family 36.

Foucault M, Watzlawick H, Mattes R, Haser R, Gouet P.

Acta Crystallogr Sect F Struct Biol Cryst Commun. 2006 Feb 1;62(Pt 2):100-3. Epub 2006 Jan 27.

11.

Effect of polyamine homologation on the transport and biological properties of heterocyclic amidines.

Delcros JG, Tomasi S, Duhieu S, Foucault M, Martin B, Le Roch M, Eifler-Lima V, Renault J, Uriac P.

J Med Chem. 2006 Jan 12;49(1):232-45.

PMID:
16392808
13.

Efficacy and tolerance of mesalazine suppositories vs. hydrocortisone foam in proctitis.

Lucidarme D, Marteau P, Foucault M, Vautrin B, Filoche B.

Aliment Pharmacol Ther. 1997 Apr;11(2):335-40.

14.

[Value of the study of total alkaline phosphatases and bone isoenzyme in a population of subjects with osteoporosis].

Foucault P, Foucault MH, Kucharewicz B, Bureau F, Alix M, Drosdowsky MA.

Ann Biol Clin (Paris). 1991;49(9):477-81. French.

PMID:
1789501
15.

El nacimiento de la medicina social.

Foucault M.

Med Tradic. 1982;3(11):3-16. Spanish. No abstract available.

PMID:
11630902
16.

About the concept of the "dangerous individual" in 19th-century legal psychiatry.

Foucault M.

Int J Law Psychiatry. 1978 Feb;1(1):1-18. No abstract available.

PMID:
374291
17.

[Incorporation of the hospital into modern technology].

Foucault M.

Educ Med Salud. 1978;12(1):20-35. Spanish.

PMID:
348445
18.

Foucault & the history of classification theory.

Pratt V, Foucault M.

Stud Hist Philos Sci. 1977;8(2):163-71. No abstract available.

PMID:
11620599
19.

[History of medicalization].

Foucault M.

Educ Med Salud. 1977;11(1):3-25. Spanish. No abstract available.

PMID:
326534
20.

[The crisis of medicine or the antimedicine crisis].

Foucault M.

Educ Med Salud. 1976;10(2):152-70. Spanish.

PMID:
780092
21.

[Meningoencephalitis due to Listeria monocytogenes (apropos of 6 cases)].

Lambert P, Foucault M, Petit H, Warot P.

Lille Med. 1972 Feb;17(2):238-41. French. No abstract available.

PMID:
4624890
22.

[Effects of the micronized aldactone - altizide combination in the treatment of edema].

Lekiefre J, Foucault M, Basin B, Delemotte M.

Lille Med. 1966 Jun-Jul;11(6):730-3. French. No abstract available.

PMID:
5942193
23.

[Dichlorphenamide, new diuretic carbonic anhydrase inhibitor. Therapeutic trial].

DOUMER E, LORRIAUX A, LEBLOIS J, FOUCAULT M.

Lille Med. 1960 Oct;5:735-9. French. No abstract available.

PMID:
13724087
24.

Perspectives de la pénicillinothérapie buccale après 20 mois d'expérimentation.

BLECHMANN G, MONTLAUR JH, FOUCAULT M.

Arch Hosp (Paris). 1949 Dec;21(12):361. Undetermined Language. No abstract available.

PMID:
15401370

Supplemental Content

Loading ...
Support Center